Human immunoglobulin allotypes:  possible implications for immunogenicity.
Jefferis
Roy
R
School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK. r.jefferis@bham.ac.uk
Lefranc
Marie-Paule
MP
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003141:Communicable Diseases / Q000188:drug therapy*; D006801:Humans; D055261:Immunogenetic Phenomena; D007126:Immunoglobulin Allotypes / Q000145:classification / Q000235:genetics; D007143:Immunoglobulin Heavy Chains / Q000627:therapeutic use; D007147:Immunoglobulin Light Chains / Q000627:therapeutic use; D011110:Polymorphism, Genetic; D011994:Recombinant Proteins / Q000235:genetics / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D007126:Immunoglobulin Allotypes; D007143:Immunoglobulin Heavy Chains; D007147:Immunoglobulin Light Chains; D011994:Recombinant Proteins